Chatterjee N - Search Results

1

A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer.

Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE, Wacholder S, Wang Z, Welch R, Hutchinson A, Wang J, Yu K, Chatterjee N, Orr N, Willett WC, Colditz GA, Ziegler RG, Berg CD, Buys SS, McCarty CA, Feigelson HS, Calle EE, Thun MJ, Hayes RB, Tucker M, Gerhard DS, Fraumeni JF Jr, Hoover RN, Thomas G, Chanock SJ. Hunter DJ, et al. Among authors: chatterjee n. Nat Genet. 2007 Jul;39(7):870-4. doi: 10.1038/ng2075. Epub 2007 May 27. Nat Genet. 2007. PMID: 17529973 Free PMC article.

2

A marginal likelihood approach for estimating penetrance from kin-cohort designs.

Chatterjee N, Wacholder S. Chatterjee N, et al. Biometrics. 2001 Mar;57(1):245-52. doi: 10.1111/j.0006-341x.2001.00245.x. Biometrics. 2001. PMID: 11252606

3

Association and aggregation analysis using kin-cohort designs with applications to genotype and family history data from the Washington Ashkenazi Study.

Chatterjee N, Shih J, Hartge P, Brody L, Tucker M, Wacholder S. Chatterjee N, et al. Genet Epidemiol. 2001 Sep;21(2):123-38. doi: 10.1002/gepi.1022. Genet Epidemiol. 2001. PMID: 11507721

4

Breast cancer risk in Ashkenazi BRCA1/2 mutation carriers: effects of reproductive history.

Hartge P, Chatterjee N, Wacholder S, Brody LC, Tucker MA, Struewing JP. Hartge P, et al. Among authors: chatterjee n. Epidemiology. 2002 May;13(3):255-61. doi: 10.1097/00001648-200205000-00004. Epidemiology. 2002. PMID: 11964925

5

Validation studies: bias, efficiency, and exposure assessment.

Chatterjee N, Wacholder S. Chatterjee N, et al. Epidemiology. 2002 Sep;13(5):503-6. doi: 10.1097/00001648-200209000-00004. Epidemiology. 2002. PMID: 12192218 No abstract available.

6

Joint effect of genes and environment distorted by selection biases: implications for hospital-based case-control studies.

Wacholder S, Chatterjee N, Hartge P. Wacholder S, et al. Among authors: chatterjee n. Cancer Epidemiol Biomarkers Prev. 2002 Sep;11(9):885-9. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12223433

7

The HER2 I655V polymorphism and breast cancer risk in Ashkenazim.

Rutter JL, Chatterjee N, Wacholder S, Struewing J. Rutter JL, et al. Among authors: chatterjee n. Epidemiology. 2003 Nov;14(6):694-700. doi: 10.1097/01.ede.0000083227.74669.7b. Epidemiology. 2003. PMID: 14569185

8

Adjustment for competing risk in kin-cohort estimation.

Chatterjee N, Hartge P, Wacholder S. Chatterjee N, et al. Genet Epidemiol. 2003 Dec;25(4):303-13. doi: 10.1002/gepi.10269. Genet Epidemiol. 2003. PMID: 14639700

9

Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk.

Peters U, Hayes RB, Chatterjee N, Shao W, Schoen RE, Pinsky P, Hollis BW, McGlynn KA; Prostate, Lung, Colorectal and Ovarian Cancer Screening Project Team. Peters U, et al. Among authors: chatterjee n. Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):546-52. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15066918

10

Association of genetic variants in the calcium-sensing receptor with risk of colorectal adenoma.

Peters U, Chatterjee N, Yeager M, Chanock SJ, Schoen RE, McGlynn KA, Church TR, Weissfeld JL, Schatzkin A, Hayes RB. Peters U, et al. Among authors: chatterjee n. Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2181-6. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15598778

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,124 results

Search Page

Filters